Related Experiment Video
Updated: Dec 21, 2025
10:26
Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
Published on: January 16, 2015
8.7K
Polycomb-like 2 regulates PRC2 components to affect proliferation in glioma cells
Fei Wang1, Yongying Gao2, Ye Lv3
1Department of Pathology, School of Basic Medical Sciences, Ningxia Medical University, Ningxia, 750004, China.
Journal of Neuro-Oncology
|May 22, 2020
Summary
Polycomb-like 2 (PCL2) promotes glioma cell proliferation by interacting with Polycomb Repressive Complex 2 (PRC2). This study identifies PCL2 as a potential therapeutic target for glioma, offering new research avenues.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Polycomb group (PcG) proteins regulate growth and tumorigenesis, with PRC1 and PRC2 complexes being key.
- Polycomb-like 2 (PCL2) interacts with PRC2, but its role in glioma remains undefined.
Purpose of the Study:
- To investigate the role of PCL2 in glioma development and progression.
- To explore the molecular mechanisms underlying PCL2's function in glioma.
Main Methods:
- Utilized The Cancer Genome Atlas (TCGA) database for PCL2 expression analysis.
- Performed immunohistochemical staining on 117 clinical glioma samples.
- Conducted in vitro experiments using U87/U251 glioma cells with manipulated PCL2 expression (overexpression and interference).
- Assessed cell proliferation, cell cycle, apoptosis, and Western blot analysis for PRC2 core proteins and histone methylation markers.
Main Results:
- PCL2 is highly expressed in gliomas, correlating with tumor progression.
- Overexpression of PCL2 enhances glioma cell proliferation, colony formation, and S-phase progression.
- PCL2 modulates PRC2 component expression (upregulating EZH2, EED; downregulating SUZ12) and alters histone methylation patterns (H3K27me3, H3K4me2, H3K9me2).
Conclusions:
- PCL2 acts as a crucial accessory protein for PRC2, influencing its components and histone methylation.
- PCL2 may serve as a regulatory hub for PRC2 member synergy.
- PCL2 represents a novel therapeutic target for glioma research and treatment.
Related Concept Videos
02:23Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
01:23Negative Regulator Molecules
38.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.1K
01:20The Retinoblastoma Gene
4.6K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K
01:29Somatic to iPS Cell Reprogramming
2.5K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.5K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
01:06Induced Pluripotent Stem Cells
5.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.2K